Andrew Serazin

Advisory Board Member @The Mit Press

Oxford, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Mar 2024 — Present

Advisory Board Member @The Mit Press

View department →

Boston, MA, US

Serving on Advisory Board for MIT Press focused on long-term strategy, fund raising, and new initiatives on Open Access and Scholarship.The MIT Press publishes books and journals at the intersection of science, technology, art, social science, and design. Its mission is to push the boundaries of scholarly publishing in active partnership with the MIT community and aligned with MIT‘s mission to advance knowledge in areas that will best serve the nation and the world in the twenty-first century.

EDUCATION

1999 — 2003

University of Notre Dame

Bachelor of Science, Biology

2003 — 2006

University of Oxford

Doctorate, Medical Science

SKILLS

Public SpeakingTeam LeadershipResearchStrategic PlanningFundraisingProgram ManagementNonprofit Organizations

ABOUT ANDREW SERAZIN

I believe in the transformational power of science and technology to change lives. I am currently Senior Research Fellow at Reuben College at the University of Oxford where I direct the Global Challenges Programme.I am also Co-Founder and Chair of the Board of SilvaBio, a Public Benefit Company dedicated to restoring America’s forests through advanced bioengineering, cutting-edge genomics and precision forestry. Our first breakthrough is the Darling line of blight-tolerant American chestnut trees, and we are expanding our platform to protect other threatened hardwoods, including ash, elm, and oak. From 20••••23 I was the first full-time President of Templeton World Charity Foundation. We are building interdisciplinary teams of scientists, technologists, and humanities scholars to support scientific breakthroughs and practical tools related to the search for meaning, purpose, and truth. As a malaria researcher at Oxford and Notre Dame, as well as an executive at the Bill & Melinda Gates foundation in Seattle, I worked to harness insights from unconventional thinkers to advance solutions for nutrition, maternal and child health, and infectious diseases. I founded Matatu, a venture-backed biotechnology company, with Prof. Jeffrey Gordon to demonstrate the commercial and societal value of the vast community of beneficial bacteria.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Andrew Serazin — Advisory Board Member at The Mit Press in Oxford, GB | Unifers